- Home
- YMAB vs PLBC Comparison
YMAB vs PLBC Comparison
Compare YMAB & PLBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- PLBC
- Stock Information
- Founded
- YMAB 2015
- PLBC 1980
- Country
- YMAB United States
- PLBC United States
- Employees
- YMAB N/A
- PLBC N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- PLBC Finance Companies
- Sector
- YMAB Health Care
- PLBC Finance
- Exchange
- YMAB Nasdaq
- PLBC Nasdaq
- Market Cap
- YMAB 270.5M
- PLBC 253.9M
- IPO Year
- YMAB 2018
- PLBC 2005
- Fundamental
- Price
- YMAB $5.72
- PLBC $44.24
- Analyst Decision
- YMAB Strong Buy
- PLBC Buy
- Analyst Count
- YMAB 10
- PLBC 2
- Target Price
- YMAB $21.10
- PLBC $57.00
- AVG Volume (30 Days)
- YMAB 542.6K
- PLBC 10.8K
- Earning Date
- YMAB 03-04-2025
- PLBC 04-16-2025
- Dividend Yield
- YMAB N/A
- PLBC 2.71%
- EPS Growth
- YMAB N/A
- PLBC N/A
- EPS
- YMAB N/A
- PLBC 4.80
- Revenue
- YMAB $84,553,000.00
- PLBC $81,275,000.00
- Revenue This Year
- YMAB $6.41
- PLBC N/A
- Revenue Next Year
- YMAB $18.15
- PLBC $22.44
- P/E Ratio
- YMAB N/A
- PLBC $9.22
- Revenue Growth
- YMAB N/A
- PLBC 4.55
- 52 Week Low
- YMAB $5.60
- PLBC $32.50
- 52 Week High
- YMAB $20.90
- PLBC $51.33
- Technical
- Relative Strength Index (RSI)
- YMAB 35.08
- PLBC 40.76
- Support Level
- YMAB $5.60
- PLBC $44.43
- Resistance Level
- YMAB $6.57
- PLBC $46.11
- Average True Range (ATR)
- YMAB 0.38
- PLBC 1.09
- MACD
- YMAB 0.10
- PLBC -0.15
- Stochastic Oscillator
- YMAB 11.43
- PLBC 0.00
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About PLBC Plumas Bancorp
Plumas Bancorp is a bank holding company that provides various banking products and services in Northeastern California and Northwestern Nevada. It provides various deposit products such as checking, interest-bearing checking, business sweep, public funds sweep, savings, time deposit, and retirement accounts. The bank's loan portfolio consists of commercial real estate loans; commercial and industrial loans; consumer loans; agricultural loans; residential real estate loans, and construction and land development loans. The bank generates revenue from loans and investment securities in its portfolio and, to a lesser extent, service fees.